The use of venetoclax (ABT-199) in the treatment of CLL
Overcoming the shortfalls of ibrutinib with fludarabine in CLL patientss
Current research at Weill Cornell and the New York Genome Center
What can clonal evolution in chronic lymphocytic leukemia (CLL) tell us about outcomes?
New targets in relapsed/refractory multiple myeloma patients